BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7719417)

  • 1. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon treatment in acute progressive and fulminant hepatitis.
    Levin S; Leibowitz E; Torten J; Hahn T
    Isr J Med Sci; 1989 Jul; 25(7):364-72. PubMed ID: 2474521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
    Yoshiba M; Inoue K; Sekiyama K; Koh I
    Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon treatment of type C fulminant hepatitis].
    Yoshiba M; Inoue K; Sekiyama K
    Nihon Rinsho; 1994 Jul; 52(7):1857-64. PubMed ID: 7521431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver during and after fulminant hepatitis.
    Horney JT; Galambos JT
    Gastroenterology; 1977 Oct; 73(4 Pt 1):639-45. PubMed ID: 892367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatitis: Mayo Clinic experience with 34 cases.
    Rakela J; Lange SM; Ludwig J; Baldus WP
    Mayo Clin Proc; 1985 May; 60(5):289-92. PubMed ID: 3921780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of fulminant hepatitis with highly reliable artificial liver support and administration of interferon].
    Iwamura Y; Yoshiba M; Sugata F
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jan; 87(1):109-18. PubMed ID: 1691801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial hepatic necrosis is prognostic in fulminant liver failure.
    Ndekwe P; Ghabril MS; Zang Y; Mann SA; Cummings OW; Lin J
    World J Gastroenterol; 2017 Jun; 23(23):4303-4310. PubMed ID: 28694671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of combined plasma exchange treatment in fulminant viral hepatitis].
    Markus R; Baumgarten R; Fengler JD; Bartke D; Binus R; Fischer J; Kilger B; Miersch H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):197-204. PubMed ID: 4085389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study.
    Yoshiba M; Sekiyama K; Inoue K; Yamada M; Kako M; Nagai K; Takatori M; Iwabuchi S; Sumino Y; Tanaka K; Hakozaki Y; Hasegawa K; Shibuya A
    J Gastroenterol; 2002; 37(11):916-21. PubMed ID: 12501858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
    Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
    Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan.
    Yoshiba M; Dehara K; Inoue K; Okamoto H; Mayumi M
    Hepatology; 1994 Apr; 19(4):829-35. PubMed ID: 8138253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fulminant and subfulminant viral hepatitis].
    Bernuau J
    Rev Prat; 1990 Jun; 40(18):1652-5. PubMed ID: 2371517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium on clinical aspects in hepatitis virus infection. 2. Recent advances in acute and fulminant hepatitis in Japan.
    Mochida S; Fujiwara K
    Intern Med; 2001 Feb; 40(2):175-7. PubMed ID: 11300160
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.
    Wright TL; Mamish D; Combs C; Kim M; Donegan E; Ferrell L; Lake J; Roberts J; Ascher NL
    Lancet; 1992 Apr; 339(8799):952-5. PubMed ID: 1348798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure. Report of two cases and review of the literature.
    Meyer RA; Duffy MC
    J Clin Gastroenterol; 1993 Oct; 17(3):231-4. PubMed ID: 8228085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M
    Gastroenterol Jpn; 1990 Feb; 25(1):70-7. PubMed ID: 2106467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and immunohistochemical features of fulminant delta hepatitis.
    Govindarajan S; de Cock KM; Peters RL
    Hum Pathol; 1985 Mar; 16(3):262-7. PubMed ID: 3882550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of non A, non B, non C hepatitis that relapsed into fulminant hepatic failure.
    Cuffari C; Brochu P; Russo P; Alvarez F
    Hepatogastroenterology; 1998; 45(24):2348-51. PubMed ID: 9951921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant viral hepatitis.
    Fagan EA; Williams R
    Br Med Bull; 1990 Apr; 46(2):462-80. PubMed ID: 2116214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.